Active Ingredient: BUDESONIDE
Proprietary Name: BUDESONIDE
Dosage Form; Route of Administration: SUSPENSION; INHALATION
Strength: 0.5MG/2ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AN
Application Number: A216667
Product Number: 001
Approval Date: Nov 29, 2023
Applicant Holder Full Name: EUGIA PHARMA SPECIALITIES LTD
Marketing Status:
Prescription
Patent and Exclusivity Information